Pneumonia Clinical Trial
Official title:
Assessing the Health Impact of Advance Water Filters and Improved Cookstoves in Western Province, Rwanda: A Cluster-randomised Controlled Trial
DelAgua Health Rwanda (Implementation) Ltd. together with Rwanda Ministry of Health (MoH)
are delivering an intervention, consisting on the free distribution of one advance water
filter and one improved cookstove to all household classified as ubudehe 1 and 2 according
to government approved registers (poorest tertile), in Western Province. The aim of this
intervention is to reduce the morbidity and mortality associated with diarrhoeal diseases
and pneumonia in Rwanda.
The London School of Hygiene and Tropical Medicine (LSHTM) will be undertaking an
independent evaluation of this large-scale intervention to assess its impact on health. The
trial will evaluate whether the provision of improved cookstoves and advance water filters
can reduce pneumonia and diarrhoea disease in children under 5 years of age.
A cluster randomized controlled trial (CRCT) with two arms of unequal size (3:1 ratio) will
be use to answer this question. The 96 sectors in Western Province, Rwanda, will be
randomised to either receive the intervention or the control. Each eligible household in
intervention sectors will receive one EcoZoom™ Spartan and one Vestergaard Frandsen
Lifestraw Family™ 2.1 water filter free of charge. Eligible households in control sectors
will continue with their traditional cooking and drinking practices. Health data on children
under 5 years of age will be collected from community health worker (CHW) and health
facility records all across Western Province to evaluate the health impact of the
intervention. The study will encompass 12 months of follow-up. After this time the control
sectors will receive the intervention.
This independent evaluation will also include a nested village-level study within the larger
sector-level study, with the aim to evaluate uptake, consistent use and acceptability of the
intervention, as well as to assess the impact on environmental exposures and health
outcomes. 174 villages (74 controls and 74 intervention) will be selected for participation.
Household surveys will be used to collect data on intervention use and acceptability as well
as on self-reported health data. Water samples will be collected and monitoring of exposure
to Households Air Pollution (HAP) will be undertaken. Measurements of blood pressure,
expirated Carbon monoxide (CO) and pulse CO-oximetry will be undertake in primary cooks and
or children under 5 years of age. Additionally, as part of this nested study, two
exploratory studies will also be conducted. One will be focused on assessing the potential
of biomarkers as indicators of environmental exposures (mainly HAP and water quality) and
health status, while the other exploratory sub-study will assess the reactivity of
participants to the use of remotely reporting electronic sensors to measure target
behaviours.
Status | Completed |
Enrollment | 1582 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 5 Years |
Eligibility |
Inclusion Criteria: - For Sector-level study: - All households shown on updated 2012 government registers to be members of ubudehe 1 and 2 in Western Province, Rwanda will be eligible to participate in the study. - For nested village-level study: - All villages from all sectors in Western province, according to official Government lists will be eligible for participation with the exception of those villages that were selected for participation in Phase 1. - At the village-level, all households that are classified as ubudehe 1 & 2 according to updated 2012 government registers, are part of the village, are able to provide informed consent, and that have at least one child under 4 years of age at the time of enrollment will be eligible for participation. Presence of a child under 4 years of age will be assessed by checking dates of birth or recorded age in months in the CHW register of children <5 years (Igitabo Cy'Ibikorwa Byo Gukurikirana), which are maintained at the village by CHW (though occasionally these are transferred to health centers). If this data is missing will be assesses based on CHW's report. In those cases where a village has more than the required number of participating households (10 household), a random selection of 10 households will be drawn. - For the assessment of personal exposure to HAP a stricter set of eligibility criteria will be applied. Households that comply with the following eligibility criteria will be eligible for the exposure to HAP sub-study. - Have a child 1.5-4 year old, - Have a child healthy enough to wear the monitoring equipment (as perceived by the mother), - Have a non-smoking primary cook, - Have a primary cook that is currently not pregnant (as far as she is aware of), and - Have a primary cook that is in a healthy state to wear the monitoring equipment - The first two households identified from a randomised list will be invited to participate. - For the biomarker sub-studies, both the primary cook and the child under 4 years of age from households undergoing HAP exposure assessment will be eligible for the inflammatory cytokine biomarker study. For the enteric seroconversion study, all children aged 6 to 12 months will be eligible for participation. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Rwanda | Manna Energy Ltd. | Kigali |
Lead Sponsor | Collaborator |
---|---|
London School of Hygiene and Tropical Medicine | DelAgua, Emory University, Ministry of Health, Rwanda, National University, Rwanda, Oregon Health and Science University, Portland State University, University of Colorado, Boulder |
Rwanda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Prevalence of IMCI defined pneumonia in children under 5 years of age in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Prevalence of IMCI defined diarrhoea in children under 5 years of age in ubudehe 1 &2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Prevalence of self-reported diarrhoea among primary cooks | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Prevalence of self-reported respiratory conditions among primary cooks in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Mena difference in blood pressure in primary cooks in ubudehe 1 and 2 categories | Mean difference of systolic and diastolic measured separately. This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Mean difference in levels of expirated CO in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Mean difference levels of Carboxyhaemoglobin in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Percentage seroconversion against enteric pathogens in children 6-12 months of age at enrolment in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Mean difference in inflammatory cytokines in children under 5 years of age in unudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Median difference in 48-h personal exposure to PM2.5 in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Other | Levels of faecal contamination in drinking water | This outcome measure will be assessed in the nested village-level study. Proportion of water samples samples free of faecal contamination. | 12 months | No |
Other | Levels of consistent use of the intervention | This outcome measure will be assessed in the intervention group only of the nested village-level study. Percentage of households reporting the use of the stove as their primary stove in all follow-up visits. Percentage of households reporting their current drinking water was treated by the intervention filter in all follow-up visits. |
12 months | No |
Primary | Incidence of IMCI defined pneumonia in children under 5 years of age in ubudehe 1 & 2 categories | All types of pneumonia (severe, non severe). This outcome measure will be assessed in the sector-level study. | 12 months | No |
Primary | Incidence of IMCI defined diarrhoea in children under 5 years of age in ubudehe 1 & 2 categories | All types of diarrhoea (including severe, persistent, dysentery). This outcome measure will be assessed in the sector-level study. | 12 months | No |
Secondary | All-cause mortality in children under 5 years of age in ubudehe 1 & categories | This outcome measure will be assessed in the sector-level study. | 12 months | No |
Secondary | Incidence of maternal health outcomes among women un ubudehe 1 & 2 categories | Incidence of maternal health outcomes including low birth weight, premature birth, and still birth | 12 months | No |
Secondary | Prevalence of self-reported diarrhoea in children under 5 years of age in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Secondary | Prevalence of pneumonia in children under 5 years of age in ubudehe 1 & 2 categories | This outcome measure will be assessed in the nested village-level study. | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
Completed |
NCT05815264 -
Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above
|
Phase 1 | |
Recruiting |
NCT04589936 -
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care
|
N/A | |
Completed |
NCT02905383 -
The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital
|
N/A | |
Completed |
NCT06210737 -
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years
|
Phase 4 | |
Terminated |
NCT03944551 -
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
|
N/A | |
Terminated |
NCT04660084 -
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT05702788 -
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
|
Phase 2 | |
Not yet recruiting |
NCT04171674 -
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.
|
N/A | |
Active, not recruiting |
NCT03140163 -
Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR]
|
N/A | |
Completed |
NCT02864420 -
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
|
N/A | |
Completed |
NCT02638649 -
Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
|
||
Recruiting |
NCT02515565 -
Physiotherapy in Patients Hospitalized Due to Pneumonia.
|
N/A | |
Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
Completed |
NCT01416519 -
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
|
N/A | |
Completed |
NCT01446926 -
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
|
Phase 1 | |
Completed |
NCT01399723 -
Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
|
Phase 3 | |
Terminated |
NCT02358642 -
Drug to Prevent Pneumonia in the Tube Fed
|
Phase 4 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A |